C3orf17 Activators
C3orf17 Activators are molecules that interact directly with the C3orf17 protein or modulate its expression by influencing the gene's regulatory elements. The mode of action for these activators vary: they might bind to the C3orf17 protein to induce a conformational change that results in increased activity, or they might interact with promoter regions of the gene to enhance transcription. These activators are be diverse in structure, ranging from small organic molecules to larger biomolecules, and can be identified through various biochemical and molecular biology techniques, such as high-throughput screening, computational modeling, or mutagenesis studies.
The study and identification of C3orf17 Activators could contribute significantly to the understanding of the function of the C3orf17 protein within cellular processes. By artificially modulating the activity of C3orf17, researchers could observe the resulting phenotypic changes in cells or organisms, which would help clarify the role of this protein in biological systems. Furthermore, such activators could serve as molecular probes to dissect the pathways and interactions in which C3orf17 is involved, potentially highlighting its involvement in cellular networks and biological mechanisms. The ability to manipulate the activity of C3orf17 through chemical activators would thus be a powerful approach in basic research to further comprehend the complexities of protein function and gene regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, leading to increased cAMP levels. This amplification of cAMP signaling could indirectly enhance C3orf17's functional activity if C3orf17 is involved in pathways regulated by cAMP. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin gallate is known to inhibit certain kinases, which may lead to the reduction of competitive signaling pathways and potentially enhance the pathways where C3orf17 is active. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
This compound is involved in the sphingolipid signaling pathway, which can influence numerous cellular processes including those that C3orf17 may be a part of, potentially enhancing its functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY 294002 is a PI3K inhibitor which could shift cellular signaling towards pathways in which C3orf17 is involved, thereby enhancing its activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates PKC which is involved in various signaling pathways. If C3orf17 is part of any pathway downstream of PKC, this activation could lead to an enhancement of C3orf17's functions. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin elevates intracellular calcium levels, potentially activating calcium-dependent signaling pathways and thereby enhancing the activity of C3orf17 if it is involved in such pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB 203580 is an inhibitor of p38 MAPK. Inhibition of p38 could lead to the enhancement of alternative pathways, potentially increasing the activity of C3orf17. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is a tyrosine kinase inhibitor which could reduce competitive signaling and enhance the pathways where C3orf17 operates, potentially increasing its activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor, which could lead to the selective activation of pathways involving C3orf17 by relieving specific kinase-mediated inhibition. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, which could enhance C3orf17 activity if it is linked to calcium-dependent signaling. | ||||||